Elena Henkel
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research, Cardiovascular Health and Disease Prevention, Diabetes Treatment and Management, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial(2017)557 cited
- → Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.(2000)545 cited
- → Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial(2019)330 cited
- → The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial(2015)272 cited
- → Acarbose Slows Progression of Intima-Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance(2004)254 cited
- → Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose(2003)241 cited
- → Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes(2002)156 cited
- → Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors.(1999)149 cited
- → Post‐challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima‐media thickness: the RIAD Study(2000)118 cited
- → Impaired fasting glucose is not a risk factor for atherosclerosis(1999)86 cited